ANW Intrinsic Valuation and Fundamental Analysis - Immuron Ltd

I	Immuron Ltd SWB:ANW	AU
	OSE Immunotherapeutics SA OTC:ORPOF	FR
A	Advantest Corp DUS:VAN	JP
S	Siemens Energy AG XMUN:ENR	DE
C	Canadian Net Real Estate Investment Trust OTC:CNNRF	CA
B	Belden Inc XMUN:QCTA	US
I	Imperial Oil Ltd XMUN:IMP	CA
E	ENEFI Vagyonkezelo Nyrt WSE:EST	HU
P	Palfinger AG XMUN:PFI	AT
	Prescient Therapeutics Ltd F:UDD	AU

Intrinsic Value

Is ANW undervalued or overvalued?

See the intrinsic value estimate for Immuron Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

ANW Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with ANW’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Margin of Safety 20% Locked

Current Price €0.06

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What Immuron Does

Biotechnology Health Care

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada.

Headquarters: Australia AU
Employees: 7
IPO date: Apr 30, 1999